Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04642261
What this trial is testing

Effect of Empagliflozin on Liver Fat in Non-diabetic Patients

Who this might be right for
Non-alcoholic Fatty Liver Disease
The University of Hong Kong 98
Not applicableUnknownNCT01281059
What this trial is testing

Prediction of Severity of Liver Disease Non Alcoholic Fatty Liver Disease in Patients With Suspected NAFLD by a 13C Octanoate Breath Test

Who this might be right for
NAFLD
Hadassah Medical Organization
Not applicableStudy completedNCT04786418
What this trial is testing

Low-Calorie Diet in People With Prediabetes/Metabolic Syndrome

Who this might be right for
ObesityNAFLDFatty Liver+2 more
University of Liverpool 44
Very early researchWithdrawnNCT01807910
What this trial is testing

ER Stress in NAFLD

Who this might be right for
ObesityNAFLD
Vanderbilt University
Testing effectiveness (Phase 2)Study completedNCT03371355
What this trial is testing

Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLDDiabetes Mellitus, Type 2Hypertriglyceridemia+1 more
Akcea Therapeutics 105
Not applicableUnknownNCT04099147
What this trial is testing

Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Instituto de Investigación Marqués de Valdecilla 14,046
Not applicableLooking for participantsNCT03025074
What this trial is testing

Blood Collection Biorepository for Liver Disease Research

Who this might be right for
Non-Alcoholic Steatohepatitis(NASH)Hepatitis CHepatitis B+5 more
State University of New York at Buffalo 1,000
Post-approval studies (Phase 4)Study completedNCT05647915
What this trial is testing

Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals with Obesity and NAFLD

Who this might be right for
ObesityObesity, AbdominalNAFLD
China National Center for Cardiovascular Diseases 337
Not applicableStudy completedNCT05946148
What this trial is testing

Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseLiver Steatosis
National and Kapodistrian University of Athens 78
Testing effectiveness (Phase 2)Ended earlyNCT04175392
What this trial is testing

Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis

Who this might be right for
Fatty Liver DiseaseFibrosis, LiverCirrhosis, Liver+1 more
Corewell Health East 14
Testing effectiveness (Phase 2)UnknownNCT00699036
What this trial is testing

Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic SteatohepatitisNonalcoholic Fatty Liver Disease
Brooke Army Medical Center 165
Not applicableStudy completedNCT03774511
What this trial is testing

Effects of Exercise on Patients With Nonalcoholic Fatty Liver Disease- A Comparative Randomized Controlled Trial

Who this might be right for
DiabetesNonalcoholic Fatty Liver DiseaseObesity+1 more
Ahlia University 48
Not applicableEnded earlyNCT02345421
What this trial is testing

Identify and Characterize LAL-D Patients in High-risk Populations

Who this might be right for
Lysosomal Acid Lipase Deficiency
Alexion Pharmaceuticals, Inc. 640
Testing effectiveness (Phase 2)Active Not RecruitingNCT05583344
What this trial is testing

Phase 2b Study of GSK4532990 in Adults With NASH

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNon-alcoholic Fatty Liver Disease
GlaxoSmithKline 284
Not applicableStudy completedNCT01100398
What this trial is testing

Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy

Who this might be right for
Fatty Liver
Brooke Army Medical Center 400
Not applicableActive Not RecruitingNCT04820036
What this trial is testing

A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)Endoscopic Sleeve GastroplastyNon-alcoholic Fatty Liver Disease (NAFLD)+4 more
Brigham and Women's Hospital 20
Testing effectiveness (Phase 2)Study completedNCT03400163
What this trial is testing

A Sub-study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-Alcoholic Steatohepatitis
Bristol-Myers Squibb 3
Post-approval studies (Phase 4)Study completedNCT02875821
What this trial is testing

Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone

Who this might be right for
Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD)
Yonsei University 44
Not applicableUnknownNCT02400099
What this trial is testing

Protein-rich Diet and NAFLD in Bariatric Surgery

Who this might be right for
ObesityNon-alcoholic Fatty Liver Disease
Catholic University of the Sacred Heart 60
Not applicableStudy completedNCT05764811
What this trial is testing

SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With Obesity

Who this might be right for
Fatty Liver Disease
National Cheng-Kung University Hospital 40
Next Page